OBJECTIVE When to suspect a paraneoplastic disorder is a puzzling problem that has not recently been studied in a large series of patients referred for peripheral neuropathy. METHODS From 422 ...

Objectives: Several serum antibodies against gangliosides are diagnostically important, particularly in Guillain-Barré syndrome (GBS), Miller Fisher syndrome (MFS), and multifocal motor neuropathy ...

Peripheral neuropathy is the term for damage to nerves of the peripheral nervous system, which may be caused either by diseases of or trauma to the nerve or the side-effects of systemic illness ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

Reactivation of HSV-1 has been reported most frequently and is one of the most likely causes of the condition in adults. [9, 10] VZV reactivation can also cause acute peripheral facial paralysis ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

Medically reviewed by Andrew Greenberg, MD Peripheral vision is what you see beyond your direct line of sight. It helps provide a complete sense of your surroundings without moving your head. Jump to ...

New guidelines from the American College of Cardiology and American Heart Association update best practices for managing peripheral artery disease (PAD). The comprehensive clinical guidelines synopsis ...

During the development of peripheral nerves, neural crest cells generate myelinating and non-myelinating glial cells in a process that parallels gliogenesis from the germinal layers of the CNS ...

Background: The purpose of this study was to determine if gabapentin, an anti-convulsant used for neuropathic pain, is effective in improving pain and symptoms due to chemotherapy-induced peripheral ...

Acute or chronic upper limb ischemia is an uncommon condition [1, 2, 3] that is responsible for between 15 and 18% of the procedures undertaken for critically ischemic limbs. [4, 5] Thromboembolic ...

Partner Therapeutics, Inc. (PTx) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of PTx's Marketing ...